Alobar holoprosencephaly is a severe genetic brain development disorder in which the front of the brain does not divide into two hemispheres before birth. Babies often have serious features at birth, such as very small head size, facial differences involving the eyes, nose, or upper lip, poor muscle tone, feeding and breathing difficulties, and seizures; many also have heart, endocrine, or other organ issues. This condition is typically recognized during pregnancy or immediately after delivery, and sadly it is usually life‑limiting, with many pregnancies ending in miscarriage or stillbirth and most affected newborns surviving hours to days; a small number live longer with intensive medical support. Care focuses on comfort, breathing and feeding support, seizure control, and coordinated care from neonatology, neurology, and palliative teams. Genetic testing can sometimes clarify why alobar holoprosencephaly occurred and help families understand recurrence risks for future pregnancies.
How many people live with Alobar holoprosencephaly?
Direct counts of how many people are living with alobar holoprosencephaly are not available; using widely cited birth‑prevalence figures for the broader condition holoprosencephaly (about 1 in 10,000–20,000 live births) with 2020 birth totals, that suggests roughly 7,000–14,000 holoprosencephaly births worldwide in 2020 and about 185–370 in the United States in 2020. Alobar cases may account for about 20%–40% of holoprosencephaly, suggesting roughly 1,400–5,600 global births and 37–148 U.S. births in 2020—an estimate for scale, not a direct count of how many people are currently living with the condition.
Overview
Alobar holoprosencephalySymptoms
Alobar holoprosencephaly is usually recognized before birth or at delivery. Signs include severe brain underdevelopment with midline facial differences (closely spaced eyes, cleft lip/palate), poor muscle tone, seizures, and serious breathing and feeding problems. Many newborns need intensive support immediately.
Outlook and prognosis
Alobar holoprosencephaly is the most severe form of holoprosencephaly and often leads to life‑limiting complications before or shortly after birth. Survival beyond the newborn period is uncommon, and significant medical support is typically needed. Parents benefit from early, compassionate counseling and coordinated perinatal and palliative care.
Causes and risk factors
Alobar holoprosencephaly usually results from chromosomal changes (often trisomy 13) or single‑gene variants (e.g., SHH), occasionally autosomal dominant. Risk rises with pregestational diabetes, alcohol or retinoic‑acid exposure, and cholesterol‑synthesis disorders. Many cases are de novo; advanced maternal age increases risk.
Genetic influences
Genetics plays a major role in alobar holoprosencephaly, with many cases linked to gene changes or chromosomal differences. Variants in several developmental genes and conditions like trisomy 13 are well-known causes. Still, some cases have no identifiable genetic cause.
Diagnosis
Diagnosis of Alobar holoprosencephaly relies on characteristic clinical features and imaging findings on prenatal ultrasound or MRI. Genetic diagnosis of Alobar holoprosencephaly uses chromosomal studies or gene panels to identify causes. Postnatal MRI and exam confirm severity.
Treatment and drugs
Treatment for alobar holoprosencephaly focuses on comfort, stabilizing breathing and feeding, and preventing complications like seizures and infections. Care often includes NICU support, seizure medicines, feeding support, and careful fluid and temperature management. Families receive early palliative care, nursing support, and genetic counseling.
Symptoms
Care needs often start before birth and continue from the first moments of life. Alobar holoprosencephaly affects how the brain and face form very early in pregnancy, so signs are often present before birth or right at delivery. Early features of alobar holoprosencephaly may appear on a routine ultrasound and can include limited separation of the brain and midline facial differences. Newborns usually have severe medical needs, such as trouble breathing and feeding, and often need care in a neonatal intensive care unit.
Routine ultrasound or fetal MRI may show that the brain did not separate into two halves. This sign of alobar holoprosencephaly is often visible during pregnancy.
Features can include very closely spaced eyes, a single eye, a small or absent nose, or a single nostril. These midline differences are common in alobar holoprosencephaly.
The head may be smaller than expected or shaped differently. The forehead and midface can look flatter than usual.
Newborns often have a weak suck and trouble coordinating swallowing. Many need a feeding tube to get enough nutrition safely.
How people usually first notice Alobar holoprosencephaly?
Many families first learn something is different during pregnancy, when an ultrasound or fetal MRI shows the “first signs of alobar holoprosencephaly,” such as a single large brain cavity, very closely spaced or fused brain structures, and sometimes facial differences like a single midline eye socket or a very small or absent nose. If not detected prenatally, doctors usually notice “how alobar holoprosencephaly is first noticed” at birth because the baby may have severe facial differences, trouble breathing, poor feeding, and very low muscle tone, prompting urgent imaging. In most cases, the condition is recognized before or immediately after birth due to its striking brain and facial features.
Types of Alobar holoprosencephaly
Alobar holoprosencephaly is the most severe end of a genetic and developmental brain condition that has recognized clinical variants. Here, “types of alobar holoprosencephaly” usually refer to how the brain fails to divide and the facial differences that tend to go with it. Not everyone will experience every type. Doctors often also describe related, less severe variants in the same family of conditions that differ in brain separation and survival.
Classic alobar type
The forebrain does not split into two halves, leading to a single large brain cavity. Facial differences are usually pronounced, and breathing and feeding problems start at birth. Survival is typically very limited.
Semilobar variant
The brain separates a little in the back but remains fused toward the front. Facial differences may be less marked than in classic alobar type. Some newborns survive longer but often have severe neurologic challenges.
Syntelencephaly pattern
The middle parts of the brain remain fused while the front and back separate more. Facial features can look milder than expected for the level of brain fusion. Developmental outcomes vary but are generally serious.
Middle interhemispheric variant
Separation fails mainly across the middle of the brain’s surface. Many living with this variant have tight muscle tone, seizures, and feeding difficulties. Facial differences may be subtle or absent.
Microform spectrum
Brain separation may be near normal, with mostly facial signs such as a single front tooth or closely spaced eyes. Neurologic symptoms can still occur depending on internal brain differences. Loved ones may recognize certain types sooner than the person experiencing them.
Can I slow down the onset of symptoms?
No—there isn’t a way to slow the onset of symptoms in alobar holoprosencephaly, because this condition develops very early in pregnancy and signs are present at or before birth. While nothing can delay symptoms once it is present, steps before and during pregnancy—such as good blood sugar control if you have diabetes, avoiding alcohol, and reviewing medicines with your clinician—may lower the chance in a future pregnancy, and prenatal screening can identify it earlier. If you’re planning a pregnancy or have a family history, a genetic counselor or high-risk pregnancy specialist can help you understand risks and options, but no approach can guarantee prevention.
What genetics can tell you about symptoms
Certain genetic changes in SHH, ZIC2, SIX3, or Trisomy 13 can disrupt early brain patterning, leading to alobar holoprosencephaly with a single brain ventricle, severe facial differences (like cyclopia or a single nostril), seizures, and feeding or breathing problems. These variants alter “signaling switches” that guide the forebrain to split, so when signaling is reduced or mistimed, both brain and midline facial features develop incompletely.
Causes and risk factors
Most cases of alobar holoprosencephaly trace back to changes in chromosomes (commonly trisomy 13 or triploidy) or variants in genes that guide very early brain development, such as SHH, ZIC2, or SIX3; many happen for the first time in a pregnancy with no family history. Some cases are part of a broader chromosome condition linked to increasing maternal age, while others can be inherited from a parent, with wide differences in how strongly the condition shows up.
Environmental and health-related risks during early pregnancy include pre‑existing diabetes that is poorly controlled, exposure to alcohol, and certain medicines like isotretinoin (a vitamin A–related acne drug), all of which can disrupt forebrain formation. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Because causes and risk factors of alobar holoprosencephaly vary, meeting with a genetics team can clarify recurrence risk for a future pregnancy and whether genetic testing is appropriate.
What are the most common causes or risk factors?
Alobar holoprosencephaly is most often linked to genetic changes, especially having an extra copy of chromosome 13, and sometimes changes in single genes that guide early brain and face development. Risk can also be higher with diabetes that was present before pregnancy and is not well controlled, and with certain early‑pregnancy exposures such as heavy alcohol use, the acne drug isotretinoin (a strong form of vitamin A), or some anti‑seizure medicines. The chance may also rise with older age in pregnancy (because chromosome problems are more common) and in families with a history of similar birth differences, including when parents are closely related (for example, cousins).
Environmental and biological risk factors
Alobar holoprosencephaly starts very early in pregnancy, when the front of the brain is forming. Most cases are not linked to anything a parent did, but certain body-based and environmental factors can raise the chance it occurs. Doctors often group risks into internal (biological) and external (environmental). Below are environmental and biological risk factors for alobar holoprosencephaly, especially when exposures happen in the first few weeks after conception.
High blood sugar around conception and in the first trimester is linked to a higher chance of midline brain development problems, including alobar holoprosencephaly. The risk is greatest when diabetes is present before pregnancy and blood sugars run high early on.
Conception at older ages is associated with a higher overall risk of severe brain and facial development differences in the fetus. This age-related risk is small for any one pregnancy but rises steadily with maternal age.
Exposure to isotretinoin, acitretin, or very high-dose vitamin A in early pregnancy can disrupt brain and face formation. First‑trimester exposure carries the highest risk.
The brain’s midline separates during weeks 3–4 after conception, a brief period when development is highly sensitive. Harmful exposures during this window can have a larger impact than the same exposures later on.
Genetic risk factors
Genetic changes are a common driver of alobar holoprosencephaly, from extra or missing chromosome material to variants in key brain-development genes. Although early symptoms of alobar holoprosencephaly are usually found on prenatal ultrasound, the underlying risk often traces back to these inherited or new DNA changes. Carrying a genetic change doesn’t guarantee the condition will appear. A genetics team can help clarify which type of change is present and what it means for future pregnancies.
Trisomy 13 or triploidy: An extra chromosome 13 or a whole extra set of chromosomes is a leading genetic cause of alobar holoprosencephaly. These changes start at conception and disrupt early brain separation. They usually happen as new events and are not inherited from a parent.
Other aneuploidies: Less often, other chromosome-number changes such as trisomy 18 are linked to holoprosencephaly. The risk for severe forms depends on how much genetic imbalance is present. Mosaic forms may have milder or variable effects.
SHH gene changes: Variants in the SHH gene, a key brain-patterning signal, can cause holoprosencephaly including alobar forms. When SHH is altered, the front of the brain may not split into two halves as it should. These variants can be inherited or arise for the first time in a child.
ZIC2 variants: Changes in the ZIC2 gene are a frequent single-gene cause of holoprosencephaly. Many are new (de novo) changes, and recurrence risk is usually low if parents test negative. Some families can carry and pass on these variants.
SIX3 variants: Variants in SIX3 can lead to alobar holoprosencephaly or less severe types in the same family. Severity can vary widely, even between close relatives. Genetic counseling can explain inheritance and testing options.
TGIF1 variants: Changes in TGIF1 on chromosome 18p can contribute to holoprosencephaly. Effects range from no outward signs in a parent to severe brain involvement in a child. Testing parents helps estimate recurrence risk.
Copy-number variants: Small missing or extra chromosome pieces that include HPE genes, especially on 7q36, 13q, or 18p, can cause alobar holoprosencephaly. These microdeletions or microduplications are often found with chromosomal microarray. Some occur as new events, while others are inherited.
Other pathway genes: Less common variants in related signaling genes such as GLI2, FGF8, FGFR1, or CDON have been reported in holoprosencephaly. Their effects range from mild facial differences to severe outcomes. A gene panel test may be suggested when first-line testing is negative.
Familial inheritance patterns: Many single-gene causes follow autosomal dominant inheritance with incomplete penetrance. In some families a parent has mild or no features, while a child has alobar holoprosencephaly. People with the same risk factor can have very different experiences.
Parental translocations: A parent with a balanced rearrangement involving key regions for brain development can have an increased risk of a pregnancy with holoprosencephaly. Blood chromosome testing in parents can identify this. Results guide recurrence-risk estimates and prenatal testing choices.
Parental mosaicism: Occasionally, a parent has the disease-causing change in a small portion of egg or sperm cells only. This germline mosaicism can raise the chance of another child with alobar holoprosencephaly even if blood tests are negative. A genetics team may discuss targeted testing in a future pregnancy.
Lifestyle risk factors
Alobar holoprosencephaly develops very early in pregnancy, so lifestyle habits don’t cause it outright, but some choices around conception and early pregnancy can influence risk. Risk is more of a probability than a promise. When people ask about lifestyle risk factors for Alobar holoprosencephaly, they’re usually referring to habits that affect early fetal development, especially in the first weeks after conception. These center on blood sugar management, alcohol exposure, nutrition, and timely prenatal care.
Poorly controlled pre-pregnancy diabetes increases the chance of Alobar holoprosencephaly. Reaching a safe A1C before conception and keeping glucose stable in early pregnancy may lower risk.
Heavy drinking in early pregnancy has been linked with holoprosencephaly. Avoiding alcohol entirely during pregnancy removes this exposure.
Taking a prenatal vitamin with folic acid supports early brain formation. While not proven to prevent Alobar holoprosencephaly, balanced nutrition in the periconception period may help lower overall risk of major brain differences.
Regular, pregnancy-safe movement can improve insulin sensitivity and help stabilize blood sugar for those with diabetes. Better glucose control in the first trimester may reduce the chance of holoprosencephaly.
Risk prevention
Alobar holoprosencephaly develops very early in pregnancy, so true prevention isn’t always possible. Prevention is about lowering risk, not eliminating it completely. Steps focus on optimizing health before conception, avoiding known triggers during the first trimester, and using genetic counseling and early screening to make informed choices.
If you live with diabetes, aim for good glucose control before conception and in early pregnancy. Poorly controlled diabetes is a well-known risk factor for holoprosencephaly.
Before trying to conceive, review all prescription and over‑the‑counter medicines with your clinician. Some drugs (for example, isotretinoin and certain anti‑seizure medicines) can raise risk and may need safer alternatives well before pregnancy.
Avoid alcohol, tobacco, and recreational drugs when trying to conceive and during pregnancy. Alcohol and some substances have been linked to midline brain development problems, including holoprosencephaly.
If there’s a prior affected pregnancy or family history, meet with a genetics professional before conceiving. They can explain recurrence risk, discuss testing for genes and chromosomes, and review options like IVF with preimplantation genetic testing or early prenatal testing.
Can you prevent Alobar holoprosencephaly?
Alobar holoprosencephaly can’t be fully prevented, because it often happens from changes in the baby’s genes or chromosomes that occur by chance very early in pregnancy. You may be able to lower risk by going into pregnancy with well-controlled diabetes if you have it and by avoiding known harmful medicines—especially vitamin A–based acne treatments such as isotretinoin—under your clinician’s guidance. Planning care before pregnancy and getting early pregnancy care can help you understand and reduce avoidable risks, but it can’t guarantee prevention.
Transmission
Alobar holoprosencephaly is not contagious; it cannot be caught or spread. It develops very early in pregnancy and can result from a change in a single gene, a difference in the baby’s chromosomes, or (less often) certain pregnancy exposures; in many babies, this is a new change that is not inherited.
When it does run in families, genetic transmission of Alobar holoprosencephaly usually follows a dominant pattern—if a parent carries the causative gene change, each pregnancy has up to a 50% chance of inheriting it, and some carriers may have mild or no symptoms. If testing shows the change started in the child only, the chance of it happening again is usually low, but if a parent has the gene change or certain chromosome rearrangements, future risk can be higher; genetic counseling can clarify how Alobar holoprosencephaly is inherited in your family.
When to test your genes
Genetic testing is recommended as soon as alobar holoprosencephaly is suspected on prenatal imaging, to clarify the cause and guide pregnancy and newborn care. Parents may consider carrier or chromosomal testing to understand recurrence risk for future pregnancies. Early results help tailor delivery planning, neonatal support, and family counseling.
Diagnosis
Alobar holoprosencephaly is usually recognized during pregnancy scans or right after birth based on characteristic findings, then confirmed with specific tests. For some, routine check-ups reveal the first clues. Doctors focus on brain imaging and genetic tests to understand the cause, plan care, and discuss future risks. The genetic diagnosis of Alobar holoprosencephaly helps guide counseling and next steps.
Sonographers look for a single large brain cavity, missing midline separation, and facial differences such as closely spaced eyes. These imaging findings can indicate severe holoprosencephaly early in pregnancy. Results often guide referral to a fetal medicine specialist.
Detailed MRI images help confirm brain structure when ultrasound raises concern. It clarifies whether deep brain areas are fused and assesses the optic and pituitary regions. This information supports delivery and immediate care planning.
Clinicians assess facial features, breathing, feeding, and temperature control soon after birth. Findings such as midline facial differences and unstable sugars can support the diagnosis of Alobar holoprosencephaly. Early exam results guide urgent care needs.
Imaging confirms a single ventricle and absent midline separation with fused deep structures. MRI is preferred when the baby is stable; CT may be used for rapid confirmation. These imaging findings establish the diagnosis of Alobar holoprosencephaly.
How is Alobar holoprosencephaly diagnosed?
Alobar holoprosencephaly is usually first found during pregnancy on a routine ultrasound, which shows that the front of the brain has not split into two halves; a detailed ultrasound and sometimes a fetal MRI give more detail, and doctors may also see related facial differences. After birth, brain scans such as MRI or CT confirm the diagnosis and check for other concerns. Genetic testing may be offered to look for changes in chromosomes or genes that can explain the condition and guide counseling, but the diagnosis is based on the imaging findings.
Stages of Alobar holoprosencephaly
Alobar holoprosencephaly does not have defined progression stages. It is a severe structural brain difference present from early fetal development and does not progress through stepwise stages over time. Different tests may be suggested to help confirm the diagnosis, including detailed prenatal ultrasound, fetal MRI, and, after birth, head ultrasound or MRI along with a physical exam. Families often hear about prenatal diagnosis of alobar holoprosencephaly, and clinicians may also discuss genetic testing and family history to look for an underlying cause.
Outlook and prognosis
Looking ahead can feel daunting, but many families focus on making each day as comfortable and meaningful as possible. Alobar holoprosencephaly is the most severe form of holoprosencephaly, and the outlook is generally poor. Many babies with alobar holoprosencephaly do not survive pregnancy, and among those born alive, survival is often measured in hours to days. A small number live longer—weeks or, rarely, months—especially with careful supportive care for breathing problems, feeding, and seizures.
Doctors call this the prognosis—a medical word for likely outcomes. Early symptoms of alobar holoprosencephaly can include feeding difficulties, seizures, low muscle tone, and challenges with breathing and temperature control. These complications, along with heart, endocrine, or facial differences that may occur alongside the brain findings, shape survival and daily comfort. The outlook is not the same for everyone, but the overall risk of infant death remains high even with intensive medical support.
Supportive care focuses on comfort, preventing infections, managing seizures, and helping with feeding and breathing, often with input from neonatology, neurology, palliative care, and nursing. Families often want to know what role they can play.. Care teams can guide positioning for easier breathing, safe feeding strategies, and ways to ease discomfort at home or in the hospital. Talk with your doctor about what your personal outlook might look like.
Long-term effects
For alobar holoprosencephaly, most pregnancies end before birth or newborns live only hours to days. Long-term effects vary widely, but in this most severe form, outcomes are generally poor. Rare survivors live with profound, lifelong neurological and medical challenges. Families may notice early symptoms of alobar holoprosencephaly at birth, and for those who survive infancy, significant needs usually continue over time.
Many pregnancies end in miscarriage or stillbirth, and most newborns die within hours to days. In alobar holoprosencephaly, survival beyond the first weeks or months is rare.
Survivors usually have severe global developmental delay and intellectual disability. In alobar holoprosencephaly, communication and learning remain extremely limited over time.
Epileptic seizures are common and may start in infancy. In alobar holoprosencephaly, seizures often continue throughout life.
Weak suck, swallowing trouble, and reflux can lead to poor weight gain. Long-term feeding difficulties often persist as children age.
How is it to live with Alobar holoprosencephaly?
Living with alobar holoprosencephaly is profoundly challenging because the condition severely affects brain development, breathing, feeding, movement, and awareness from birth, and most babies have a very limited life expectancy despite intensive support. Daily life centers on comfort-focused care: managing seizures, helping with breathing and feeding, preventing skin problems, and creating calm, pain-free moments, often with hospice or palliative care teams guiding decisions. For parents, siblings, and caregivers, the emotional weight is immense, with frequent hospital visits, complex choices, and anticipatory grief, but many families also find meaning in routines that honor their child’s comfort and connection. Support from specialized clinicians, early-intervention services, and family counseling can ease practical burdens and help loved ones navigate the days with compassion and steadiness.
Treatment and drugs
Treatment for alobar holoprosencephaly focuses on comfort, safety, and quality of life, since there’s no way to reverse how the brain formed before birth. Care is usually supportive and coordinated by a multidisciplinary team; this can include help with breathing, feeding support such as thickened feeds or a feeding tube, seizure management with anti-seizure medicines, and careful control of body temperature and fluids. Medicines that ease symptoms are called supportive or palliative treatments, and they’re adjusted to what each child needs day to day. Some babies may need procedures to reduce fluid buildup in the brain, manage severe reflux, or protect the airway, while palliative care specialists help families plan for comfort at home or in the hospital. Your doctor can help weigh the pros and cons of each option, including hospice or home-based supports, based on your child’s specific symptoms and goals.
Can you cure Alobar holoprosencephaly?
There is no cure for alobar holoprosencephaly, a very severe brain development condition that begins early in pregnancy. Treatments cannot change how the brain formed, but care teams can provide supportive, comfort‑focused (palliative) care and manage problems such as breathing issues, seizures, or feeding difficulties. Specialists also help families with care planning and emotional and practical support.
Non-drug treatment
Care for alobar holoprosencephaly focuses on comfort, safety, and supporting daily needs from birth onward. Because early symptoms of alobar holoprosencephaly are often evident at delivery, supportive care usually begins right away in the hospital. Alongside medicines, non-drug therapies can make day-to-day care more manageable for families. Plans are individualized and may change as your child’s needs change.
A team focuses on comfort, easing distress, and aligning care with your family’s goals. They help with symptom relief, communication, and decision-making. Support can start in the newborn period and continue over time.
Specialists assess swallowing and reduce choking risk with positioning and thickened feeds. A feeding tube may be discussed if oral feeding is not safe or sufficient. Nutrition plans are adjusted to support growth and comfort in alobar holoprosencephaly.
Gentle airway suctioning, positioning, and humidification can improve breathing comfort. Monitors and safe-sleep setups help caregivers respond quickly to changes. Plans are tailored to the breathing patterns seen in alobar holoprosencephaly.
Caregivers learn seizure first aid, positioning for safety, and when to seek urgent help. Written action plans guide day-to-day responses at home. Training can reduce injury risk and caregiver stress.
Your genes may have an impact on how drugs work for you
Medications can’t correct the brain formation differences in alobar holoprosencephaly, but genes that contribute to the condition may also affect how the body handles drugs. When treatments are needed, clinicians often individualize dosing and choices, guided by genetics and careful monitoring.
Pharmacological treatments
There’s no single medicine that can cure alobar holoprosencephaly; treatment focuses on easing symptoms and preventing complications. Care teams tailor medications to each child’s needs, and doses often change as a child grows. Drugs that target symptoms directly are called symptomatic treatments. When medications for seizures in alobar holoprosencephaly are needed, teams adjust choices to balance benefits and side effects.
Levetiracetam or phenobarbital are common first choices; topiramate or valproate may be added if seizures persist. Levels and sedation are monitored closely.
Hydrocortisone for adrenal insufficiency, levothyroxine for low thyroid, and desmopressin for diabetes insipidus can stabilize fluids and energy. Blood salts and glucose are checked often.
Baclofen or diazepam can ease spasticity and painful tightness. Botulinum toxin injections may target a few overactive muscles.
Omeprazole or lansoprazole can reduce stomach acid and protect the esophagus. Famotidine is another option if a proton pump inhibitor is not tolerated.
Genetic influences
In alobar holoprosencephaly, genetics can play a major role in how and why the brain fails to separate early in pregnancy. The genetic causes of alobar holoprosencephaly vary: some cases are linked to extra or missing chromosomes, while others stem from a change in a single gene involved in very early brain and face development. These gene changes are often new in the child—meaning they aren’t seen in either parent—but they can also be inherited, sometimes with very different effects in relatives. Having a gene change doesn’t always mean you will develop the condition. Because different genetic routes can lead to alobar holoprosencephaly, the chance of it happening again in a future pregnancy ranges widely, from low to as high as 50% when a parent carries a gene change that strongly affects development. Testing of the baby’s chromosomes and genes, and sometimes parental testing, can clarify the cause and refine recurrence risk. Genetic counseling can help families understand what the results mean and plan next steps.
Is Alobar holoprosencephaly genetic?
Genetics plays a major role in alobar holoprosencephaly, with many cases linked to gene changes or chromosomal differences. Variants in several developmental genes and conditions like trisomy 13 are well-known causes. Still, some cases have no identifiable genetic cause.
Having a genetic risk is not necessarily a diagnosis
Genetic variants occur naturally and are widespread in the population. The majority do not affect health directly and just reflect normal human variation. For numerous genes, having a variant that has been associated with a condition indicates a potential link, not a clear-cut diagnosis, particularly when several genes and environmental influences play a role. That said, in certain situations, one well-studied change in a particular gene is enough to establish a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for alobar holoprosencephaly centers on comfort and managing seizures, feeding and reflux, and hormone issues, and genes can sometimes shape which medicines are safest and most effective. For seizures, pharmacogenetic testing for seizure medicines in alobar holoprosencephaly may guide dosing or drug choice: differences in CYP2C9 or CYP2C19 can change how the body handles phenytoin, and CYP2C19 can raise active levels of clobazam, so doctors may start with lower doses and monitor closely. Certain HLA types (such as HLA-B*15:02 or HLA-A*31:01) can raise the risk of rare but severe skin reactions with carbamazepine or oxcarbazepine, so testing is often considered—especially for people with East or Southeast Asian ancestry—before using these drugs. In children with suspected mitochondrial disease or specific POLG gene changes, valproate is usually avoided because it can trigger serious liver problems; this is one way genetics influence medication choices in alobar holoprosencephaly. Opioids sometimes used for comfort care can also be affected by genes: CYP2D6 can make codeine or tramadol too strong or not work at all, and these medicines are generally avoided in children and in anyone with breathing concerns. Genetics is only one factor—age, organ function, other medicines, and goals of care also matter, so any pharmacogenetic testing is interpreted with the full clinical picture.
Interactions with other conditions
Alobar holoprosencephaly often occurs alongside other health issues, especially chromosome differences such as trisomy 13 (Patau syndrome), which can add heart, kidney, or limb differences that shape day-to-day care. Doctors call it a “comorbidity” when two conditions occur together. If the pituitary gland is affected in alobar holoprosencephaly, hormone problems—like low cortisol, low thyroid hormone, or diabetes insipidus—can make infections, surgery, or seizures harder to manage and may require urgent treatment during illness. Seizures are common and can influence breathing, feeding, and the choice of medicines, so teams often balance anti‑seizure treatment with any hormone replacement or other therapies. Heart defects, cleft palate, and breathing or airway differences can raise the risk of aspiration and pneumonia, meaning even routine respiratory infections can have a bigger impact than usual. Because many cases are part of a broader genetic syndrome, coordinated care with genetics, neurology, cardiology, endocrinology, and palliative care can reduce complications and help align treatment with family goals.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Alobar holoprosencephaly?
On prenatal or newborn brain scans, alobar holoprosencephaly can be mistaken for hydranencephaly (when most of the brain is replaced by fluid) or severe hydrocephalus (very enlarged fluid spaces that compress the brain). It can also look similar to cases where the bridge between the two brain halves did not form (the corpus callosum is missing) or, when facial differences stand out, rare midline facial conditions such as severe clefts through the middle of the face.
History
Throughout history, people have described newborns with unusual head and facial features and severe breathing or feeding troubles, without knowing the brain had not divided properly. Midwives and families recorded losses soon after birth; some infants survived hours or days, a few longer with intensive support. These early stories reflect what we now recognize as alobar holoprosencephaly, the most severe form of a brain-splitting problem that begins very early in pregnancy.
First described in the medical literature as a single forebrain that never separates, alobar holoprosencephaly was initially understood only through outward signs seen at birth or during autopsy. As X‑rays and then early brain scans arrived in the mid‑20th century, clinicians linked the facial findings—such as closely spaced eyes or a single nostril—to the underlying brain pattern. Over time, descriptions became more precise as ultrasound offered a window into the womb, allowing families and clinicians to see the condition during the first or second trimester.
In recent decades, knowledge has built on a long tradition of observation. Widespread use of prenatal ultrasound and later fetal MRI made it possible to tell alobar holoprosencephaly apart from milder types and from other brain conditions. This shift mattered for counseling: many families wanted to understand early symptoms of alobar holoprosencephaly, expected outcomes, and options before birth. At the bedside, neonatology advanced, but outcomes for alobar holoprosencephaly remained limited because the brain’s basic layout is affected.
Advances in genetics added another layer. Researchers first noticed that alobar holoprosencephaly could run in families, sometimes alongside milder features in relatives. By the late 1990s and 2000s, gene changes in pathways that guide early brain and face development were identified, and clinicians learned that the same genetic change can lead to a spectrum—from severe alobar forms to much milder ones. This helped explain why some pregnancies are affected without a family history and why environmental factors like poorly controlled diabetes or certain exposures can play a role alongside genetics.
Despite evolving definitions, the core understanding has held: alobar holoprosencephaly begins in the first weeks after conception, when the forebrain should split into two halves but does not. Modern imaging, genetics, and better newborn care have refined diagnosis and family support, yet the historical record—spanning handwritten notes, early autopsy sketches, grainy scans, and today’s genomic reports—shows a continuous thread of observation aimed at helping families make informed decisions.